CADL
Price
$6.08
Change
+$0.21 (+3.58%)
Updated
Dec 24 closing price
Capitalization
333.78M
91 days until earnings call
Intraday BUY SELL Signals
PRTA
Price
$9.69
Change
+$0.20 (+2.11%)
Updated
Dec 24 closing price
Capitalization
521.61M
49 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CADL vs PRTA

Header iconCADL vs PRTA Comparison
Open Charts CADL vs PRTABanner chart's image
Candel Therapeutics
Price$6.08
Change+$0.21 (+3.58%)
Volume$345.87K
Capitalization333.78M
Prothena
Price$9.69
Change+$0.20 (+2.11%)
Volume$237.36K
Capitalization521.61M
CADL vs PRTA Comparison Chart in %
CADL
Daily Signal:
Gain/Loss:
PRTA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CADL vs. PRTA commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CADL is a Buy and PRTA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (CADL: $6.08 vs. PRTA: $9.69)
Brand notoriety: CADL and PRTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CADL: 43% vs. PRTA: 36%
Market capitalization -- CADL: $333.78M vs. PRTA: $521.61M
CADL [@Biotechnology] is valued at $333.78M. PRTA’s [@Biotechnology] market capitalization is $521.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CADL’s FA Score shows that 0 FA rating(s) are green whilePRTA’s FA Score has 0 green FA rating(s).

  • CADL’s FA Score: 0 green, 5 red.
  • PRTA’s FA Score: 0 green, 5 red.
According to our system of comparison, CADL is a better buy in the long-term than PRTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CADL’s TA Score shows that 6 TA indicator(s) are bullish while PRTA’s TA Score has 3 bullish TA indicator(s).

  • CADL’s TA Score: 6 bullish, 4 bearish.
  • PRTA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CADL is a better buy in the short-term than PRTA.

Price Growth

CADL (@Biotechnology) experienced а +10.55% price change this week, while PRTA (@Biotechnology) price change was +2.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

CADL is expected to report earnings on Mar 26, 2026.

PRTA is expected to report earnings on Feb 12, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRTA($522M) has a higher market cap than CADL($334M). CADL (-29.954) and PRTA (-30.036) have similar YTD gains . CADL has higher annual earnings (EBITDA): -20.74M vs. PRTA (-221.35M). PRTA has more cash in the bank: 331M vs. CADL (87M). CADL has less debt than PRTA: CADL (7.21M) vs PRTA (9.08M). PRTA has higher revenues than CADL: PRTA (11.8M) vs CADL (0).
CADLPRTACADL / PRTA
Capitalization334M522M64%
EBITDA-20.74M-221.35M9%
Gain YTD-29.954-30.036100%
P/E RatioN/AN/A-
Revenue011.8M-
Total Cash87M331M26%
Total Debt7.21M9.08M79%
FUNDAMENTALS RATINGS
PRTA: Fundamental Ratings
PRTA
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
94
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CADLPRTA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
66%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 23 days ago
77%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 7 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
CADL
Daily Signal:
Gain/Loss:
PRTA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PREPX26.740.16
+0.60%
Principal Real Estate Securities R5
LFGAX42.500.07
+0.16%
Lord Abbett Focused Growth A
CAISX11.240.01
+0.09%
Calamos International Small Cap Gr A
FCLCX44.62N/A
N/A
Fidelity Advisor Industrials C
FEQJX14.98N/A
N/A
Fidelity Advisor Hedged Equity I

CADL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with CYYNF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then CYYNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
+3.58%
CYYNF - CADL
46%
Loosely correlated
N/A
MGX - CADL
46%
Loosely correlated
+1.16%
RPTX - CADL
44%
Loosely correlated
+17.51%
RXRX - CADL
40%
Loosely correlated
+0.92%
PRTA - CADL
39%
Loosely correlated
+2.11%
More

PRTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRTA has been loosely correlated with RCKT. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if PRTA jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRTA
1D Price
Change %
PRTA100%
+2.11%
RCKT - PRTA
53%
Loosely correlated
+1.74%
SVRA - PRTA
48%
Loosely correlated
-0.62%
CADL - PRTA
38%
Loosely correlated
+3.58%
AXON - PRTA
38%
Loosely correlated
+0.02%
DNLI - PRTA
37%
Loosely correlated
+1.07%
More